amotosalen has been researched along with B Virus Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexander, SA; Gorechlad, JW; Hearst, JE; Hillyer, CD; Hossain, MS; Jaye, DL; Lezhava, L; Mittelstaedt, S; Roback, JD; Talib, S; Waller, EK | 1 |
1 other study(ies) available for amotosalen and B Virus Infection
Article | Year |
---|---|
Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Cell Division; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Epitopes, T-Lymphocyte; Furocoumarins; Graft vs Host Disease; Herpesviridae Infections; Histocompatibility Testing; Immunotherapy, Adoptive; Interferon-gamma; Isoantigens; Mice; Mice, Congenic; Mice, Inbred BALB C; Mice, Inbred C57BL; Muromegalovirus; Spleen; T-Lymphocyte Subsets; Up-Regulation; Viral Load; Virus Replication | 2003 |